XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 68,282 $ 88,277
Prepaid expenses 154,362 1,372
Total current assets 222,644 89,649
Deferred offering costs 368,802
Marketable Securities held in Trust Account 121,479,815
Total Assets 121,702,459 458,451
Current liabilities:    
Accounts payable 354,495
Accrued expenses 59,270
Accrued offering costs 70,000 142,138
Income tax payable 757,011
Total current liabilities 1,250,776 442,138
Deferred underwriting fee payable 3,450,000
Forward Purchase Agreement 8,890,000
Total Liabilities 13,590,776 442,138
Commitments and Contingencies (Note 6)
Class A ordinary shares subject to possible redemption, $0.0001 par value, 11,500,000 and 0 shares at redemption value of $10.49 and $0 per share as of September 30, 2023 and December 31, 2022, respectively 120,622,804
Shareholders’ Equity (Deficit):    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Class A ordinary shares, $0.0001 par value; 100,000,000 shares authorized; 668,875 shares issued and outstanding and 0 shares issued and outstanding (excluding 11,500,000 and 0 shares subject to possible redemption) as of September 30, 2023 and December 31, 2022, respectively 67
Class B ordinary shares, $0.0001 par value; 10,000,000 shares authorized; 4,935,622 issued and outstanding 494 494
Additional paid-in capital 24,712
Subscription receivable (206)
Accumulated deficit (12,511,682) (8,687)
Total Shareholders’ Equity (Deficit) (12,511,121) 16,313
Total Liabilities and Shareholders’ Equity (Deficit) 121,702,459 458,451
Related Party    
Current liabilities:    
Accrued expenses - related party 10,000
Promissory note - related party $ 300,000